Chronic Migraine: A Problem That Goes Beyond Analgesics
Chronic migraine is defined as the presence of 15 or more headache days per month, of which at least 8 meet migraine criteria, for a minimum period of 3 months. It affects roughly 2 to 3 percent of the Brazilian adult population — approximately 4 to 6 million people — and stands as one of the most disabling neurological conditions of our time.
Conventional pharmacological treatment (oral preventives such as topiramate, valproate, propranolol, and tricyclic antidepressants) has limited efficacy in refractory chronic migraine: only 40 to 50 percent of patients achieve a 50 percent reduction in migraine days, and most face adverse effects that limit adherence. In this setting, combining botulinum toxin type A with medical acupuncture emerges as a high-value therapeutic approach.
How Botulinum Toxin Prevents Migraine
Botulinum toxin type A (onabotulinumtoxinA — Botox® — the only one approved by the FDA and major drug regulatory agencies specifically for chronic migraine prophylaxis) works through a mechanism that goes beyond the classic neuromuscular blockade. In the migraine setting, the main target is not the muscle but the peripheral and central nociceptors involved in attack pathophysiology.
The toxin inhibits the release of CGRP (calcitonin gene-related peptide) — the central neuropeptide in migraine pathophysiology — and of glutamate from pericranial sensory nerve terminals. By reducing peripheral sensitization, it diminishes activation of the trigeminovascular complex and, consequently, the frequency and intensity of attacks.
Medical Acupuncture in Migraine: Distinct and Complementary Mechanisms
In migraine, medical acupuncture has been linked to proposed mechanisms that are complementary and non-overlapping with those of botulinum toxin. While Botox acts primarily on the inhibition of CGRP at peripheral terminals, experimental studies suggest that acupuncture can modulate the central nervous system, the autonomic axis, and the endogenous pain control systems.
The Cochrane review (Linde et al., 2016) on acupuncture for prevention of episodic migraine (not chronic) concluded that acupuncture reduces attack frequency with an effect similar to pharmacological preventives in episodic migraine. An important caveat: the data from Linde 2016 do not apply directly to chronic migraine, which is the clinical focus of Botox and of this article. The combination with botulinum toxin may act through distinct pathways:
Central serotonergic modulation
Anatomical points traditionally used for headache (designated GB20, GB21, ST36, LI4 in acupuncture cartography) have been linked, in experimental studies, to modulation of serotonergic circuits in the brainstem — with possible involvement of the nucleus raphe magnus and the locus coeruleus. Serotonin is a key neurotransmitter in migraine pathophysiology and in the descending pain control systems.
Reduction of pericranial hypersensitivity
Needling pericranial muscle points (trapezius, sternocleidomastoid, temporalis) deactivates myofascial trigger points that often amplify pain during migraine attacks. Many chronic migraine patients have concomitant cervical myofascial syndrome — acupuncture treats both conditions at once.
Autonomic and HPA axis regulation
Proposed mechanisms (largely from preclinical studies) include modulating autonomic nervous system activity — with relative reduction in sympathetic tone — and possible action on the hypothalamic-pituitary-adrenal axis. Chronic migraine patients often show autonomic dysregulation and cortisol alterations. Relative normalization of these axes has been linked to lower vulnerability to attacks.
Inhibition of central sensitization
Low-frequency electroacupuncture (2 Hz) triggers the release of beta-endorphin and dynorphin, which directly inhibit second-order neurons in the trigeminovascular complex — reducing the central sensitization that characterizes chronic migraine. This mechanism is distinct from Botox's peripheral blockade.
What the Scientific Literature Shows About the Combination
Evidence on combining acupuncture with botulinum toxin in chronic migraine, though more recent than for either modality alone, is consistent and growing. The summary below outlines the main outcomes observed in clinical studies.
How the Physician Combines the Two Therapies in Practice
Integrating the two modalities requires a physician trained in both — neurology or pain medicine for botulinum toxin, plus training in medical acupuncture. The protocol combines the schedules of both interventions to maximize therapeutic coverage across the trimester.
- Initial assessment: headache diary (minimum 30 days), HIT-6 scale, MIDAS, and cervical trigger point evaluation
- Botulinum toxin injections (PREEMPT protocol): 155 to 195 U across 31 to 39 points, every 12 weeks
- Medical acupuncture: the included studies typically used cycles of 10 to 12 sessions over the first 3 months, with points such as GB20, GB21, GV20, LI4, ST36, LR3, PC6 — frequency and duration individualized by the medical acupuncturist
- During weeks 4 to 8 (peak Botox action): combine systemic acupuncture with electroacupuncture at 2 Hz to maximize central modulation
- Dry needling at cervical and pericranial trigger points if present (trapezius, temporalis, SCM)
- Reassess with headache diary after each quarterly cycle; adjust protocol based on response
- After 6 months of good response: consider gradually spacing out acupuncture sessions toward monthly maintenance
Myths and Facts
Myth vs. Fact
Botox for migraine is cosmetic and has no scientific basis
OnabotulinumtoxinA is approved by the FDA (2010), by major drug regulatory agencies, and by leading neurology societies for chronic migraine prophylaxis. Its mechanism in migraine is neurological — it inhibits CGRP and glutamate — and is entirely distinct from cosmetic use.
Acupuncture has no evidence for migraine
The Cochrane review on acupuncture for migraine (Linde et al., 2016) included 22 clinical trials with 4,985 patients and concluded that acupuncture reduces migraine frequency at least as well as pharmacological preventives, with a superior safety profile.
The two techniques cannot be used together — they are redundant
The two techniques work through distinct, complementary mechanisms: Botox at the periphery (CGRP, nociceptors), acupuncture on the central nervous system and the autonomic axis. The combination may be additive, but high-quality randomized trials comparing it with each monotherapy are scarce and don't allow a definitive conclusion about synergy.
Frequently Asked Questions
Frequently Asked Questions
OnabotulinumtoxinA is approved for chronic migraine in many countries. Insurance coverage depends on the insurer and on specific copayments — confirm with your insurer, since regulatory approval doesn't automatically mean coverage. Check with your insurer using the specific ICD code (G43.3 — chronic migraine) along with the medical report.
Acupuncture can start as early as the day after Botox injection, provided the acupuncture points don't overlap with the injection areas. The ideal approach is to wait a few days between Botox injection and needling in the same anatomical region so the product can distribute — the exact interval varies by physician and protocol, and prescriptive literature is sparse.
It depends on the diagnosis. For EPISODIC migraine (fewer than 15 headache days per month), a Cochrane review (Linde 2016) supports acupuncture as preventive monotherapy. For CHRONIC migraine (15 or more days per month, the focus of this article), Botox (onabotulinumtoxinA) is the treatment with specific evidence (PREEMPT) and regulatory approval — equivalent evidence does not support replacing it outright with acupuncture. If you'd rather avoid injections, talk to your neurologist about preventive pharmacological options (beta-blockers, topiramate, valproate, tricyclic antidepressants, CGRP antagonists) and the complementary role of acupuncture.
The PREEMPT protocol for migraine uses low doses spread across multiple points — not the doses used cosmetically. Most patients show no perceptible change in facial expression. Mild limitation in forehead muscle movement may occur in the first few weeks and resolves on its own.
The typical protocol is 1 to 2 sessions per week during the first 4 to 6 weeks (acute phase), followed by one session per week for another 4 to 6 weeks, then monthly maintenance once response is good. For patients on concurrent Botox, the acupuncture cycle is synchronized with the quarterly injection schedule.